Bone Cancer – China Cancer Help

BONE CANCER, CHORDOMA & LIMB SALVAGE

Advanced Bone Cancer Care in China

Bone cancers, chordomas, and soft tissue sarcomas are rare and complex tumors that often resist standard radiation and chemotherapy. China provides world-leading expertise in two crucial areas: curative heavy carbon ion radiation for tough tumors of the spine and pelvis, and custom 3D-printed titanium implants that save limbs and avoid amputation in over 95% of surgical cases.

ADVANCED TREATMENT OPTIONS

Key Bone Cancer Treatments

Carbon ion particle radiation, custom 3D-printed titanium prostheses, and targeted anti-angiogenic therapies.

Carbon Ion Heavy Radiation

Intense heavy particle beams that destroy radioresistant bone tumors and chordomas while stopping safely before delicate spinal nerves and pelvic organs.

Learn More

3D-Printed Limb-Saving Surgery

Custom titanium prostheses crafted to fit your exact bone structure, successfully preserving the limb and restoring movement without amputation.

Learn More

Targeted Cell Therapies (TCR-T)

Access to cutting-edge engineered T-cell therapies (targeting NY-ESO-1 and MAGE-A4) for difficult advanced synovial and soft tissue sarcomas.

Learn More

WHY CHOOSE US

Why Choose China for Bone Cancer

A specialized clinical continuum connecting international sarcoma and chordoma patients directly with China's premier orthopedic oncology centers.

China offers unmatched clinical advantages in complex bone oncology and radioresistant sarcomas. For challenging tumors of the spine, sacrum, and pelvis—such as chordomas—China operates two of the world’s most experienced carbon ion radiotherapy centers, delivering curative radiation doses while safeguarding the spinal cord and pelvic organs.

For surgical cases, Chinese surgeons lead the world in custom 3D-printed titanium implants, routinely achieving limb salvage in complex anatomical areas that previously required amputation. Every patient is supported by a dedicated orthopedic oncology team with transparent public hospital pricing.

HOW IT WORKS

4 Steps to Treatment in China

A simple, step-by-step process from initial record review to your arrival and treatment in China.

01. Submit Records Online

Upload existing pathology reports, biomarker NGS profiles, and imaging scans through our secure clinical intake portal.

02. Pre-Screen & Doctor Match

Clinical eligibility and contraindication screening, matching your specific case with China's foremost oncology chiefs.

03. Doctor Consultation

One-on-one remote video consultation or written multidisciplinary assessment to confirm treatment protocol before travel.

04. Travel to China & Care

Expedited medical visa support, priority hospital admission, dedicated bilingual bedside escorts, and continuum follow-up.

PATIENT FAQS

Frequently Asked Questions

Key clinical, financial, and logistical insights for international patients considering care in China.

01. How does 3D-printed titanium surgery avoid amputation?

Surgeons design custom porous titanium implants based on high-resolution 3D bone CT scans. The trabecular structure encourages your own bone to grow into the implant, creating permanent structural stability and saving the limb.

02. Can carbon ion therapy treat inoperable pelvic or sacral chordomas?

Yes. Carbon ion radiotherapy is the international gold standard for radioresistant chordomas and chondrosarcomas, achieving high local tumor control without damaging the spinal cord or bowel.

03. What targeted therapies are available for advanced sarcomas?

Patients have access to approved multi-target tyrosine kinase inhibitors such as Anlotinib and Apatinib, as well as novel TCR-T cellular trials for specific antigen targets like NY-ESO-1.

04. How are international cases evaluated before travel?

Your MRI/CT scans, biopsy pathology, and surgical history are reviewed by senior orthopedic oncology surgeons and radiation physicists within 48 hours.

CONFIDENTIAL CASE EVALUATION

Start with a Confidential Clinical Case Review

Submit your basic case details below for an initial eligibility review. Our medical team coordinates directly with chief oncologists at top Chinese cancer centers, returning a preliminary assessment and roadmap within 24–48 hours.

✓ Free initial triage • ✓ Direct specialist coordination • ✓ 100% Confidential